Clinical Trial

A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated March 5, 2025 (before its estimated December 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
A study to demonstrate efficacy and safety of anakinra in pediatric and adult Japanese patients with Still's disease (Systemic juvenile idiopathic arthritis \[SJIA\] and Adult-onset Still's disease \[AOSD\]).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-04-03; most recent amendment 2026-06-23.
Status change: Active, Not Recruiting → Completed 2026-06-23
Status change: Recruiting → Active, Not Recruiting 2024-08-22
Trial Details
NCT Number NCT05814159
Lead Sponsor Swedish Orphan Biovitrum
Collaborators: CMIC Co, Ltd. Japan
Conditions Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset
Enrollment 15 participants
Start Date 2022-08-24
Primary Completion 2025-12-10 (estimated)
Study Completion 2026-06-24 (estimated)
Updated on ClinicalTrials.gov 2025-03-05